APLT NASDAQ
Applied Therapeutics, Inc.
1W: -13.6%
1M: -58.5%
3M: -85.7%
1Y: -88.3%
3Y: -87.5%
5Y: -99.6%
$0.10
Last traded 2025-12-31 — delisted
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Balance Sheet Trends
Total Assets
$87M
+58.1% ▲
5Y CAGR: +12.4%
Total Liabilities
$30M
-58.8% ▼
5Y CAGR: +13.5%
Shareholders Equity
$57M
+432.5% ▲
5Y CAGR: +11.8%
Cash & Investments
$79M
+59.1% ▲
5Y CAGR: +15.4%
Total Debt
$3M
+259.7% ▲
5Y CAGR: +6.5%
Net Debt
-$77M
-55.9% ▼
Assets vs Liabilities & Equity
Year-over-Year Growth
View Full Balance Sheet
| Line Item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 |
|---|---|---|---|---|---|
| — Assets — | |||||
| Cash | $57M | $54M | $17M | $50M | $79M |
| Short-Term Investments | $39M | $27M | $14M | $0 | $0 |
| Cash & ST Investments | $97M | $81M | $31M | $50M | $79M |
| Net Receivables | $505K | $0 | $275K | $285K | $0 |
| Inventory | $0 | $0 | $0 | $3M | $0 |
| Other Current Assets | $2M | $5M | $2M | -$434K | $461K |
| Total Current Assets | $103M | $88M | $37M | $54M | $84M |
| Property, Plant & Equip. | $2M | $1M | $1M | $447K | $3M |
| Goodwill & Intangibles | $0 | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 | $0 |
| Other Non-Current Assets | $0 | $200K | $0 | $0 | $253K |
| Total Non-Current Assets | $2M | $1M | $1M | $447K | $3M |
| Total Assets | $105M | $90M | $38M | $55M | $87M |
| — Liabilities — | |||||
| Accounts Payable | $640K | $9M | $5M | $2M | $4M |
| Short-Term Debt | $1M | $789K | $622K | $310K | $0 |
| Deferred Revenue | $0 | $0 | $0 | $667K | $212K |
| Other Current Liabilities | $3M | $987K | $25M | $56M | $7M |
| Total Current Liabilities | $21M | $26M | $33M | $71M | $27M |
| Long-Term Debt | $0 | $0 | $464K | $0 | $0 |
| Other Non-Current Liab. | $0 | $0 | $0 | $759K | $0 |
| Total Non-Current Liabilities | $1M | $891K | $878K | $797K | $2M |
| Total Liabilities | $23M | $27M | $34M | $72M | $30M |
| — Equity — | |||||
| Common Stock | $2K | $3K | $5K | $8K | $35K |
| Retained Earnings | -$161M | -$266M | -$349M | -$469M | -$574M |
| Accumulated OCI | -$112K | -$107K | $51K | $0 | $0 |
| Total Stockholders Equity | $82M | $63M | $4M | -$17M | $57M |
| Total Liabilities & Equity | $105M | $90M | $38M | $55M | $87M |
| — Key Metrics — | |||||
| Total Debt | $3M | $2M | $2M | $777K | $3M |
| Net Debt | -$55M | -$52M | -$15M | -$49M | -$77M |
| Total Investments | $39M | $27M | $14M | $0 | $0 |